Callan JMB Receives Request from the State of Texas Department of Health and Human Services to be on Standby in Response to Measles Outbreak

Rhea-AI Summary

Callan JMB (NASDAQ: CJMB) has been requested by the Texas Department of Health and Human Services to be on standby for the recent measles outbreak response. The company holds a five-year contingency contract awarded in 2023 for receiving, storing, and distributing medical countermeasures for public health emergencies.

The company is proactively submitting a 30-day roster of 24/7 available personnel to handle distribution requests. This follows their successful track record from their first emergency response contract in 2018, which was activated during the COVID-19 and MPOX pandemic, where they managed the storage and distribution of over 2 million vaccines and therapeutics.

The current measles outbreak has claimed one life, and Callan JMB is preparing to support the state's emergency response with their expert staff, equipped facilities, and quality-controlled inventory management system.

Positive

• Five-year contingency contract with Texas DSHS secured in 2023
• Proven track record in emergency response with 2M+ vaccine distribution
• Immediate readiness with 24/7 personnel availability

Negative

• None.

Insights

Public Health Emergency Response Expert

Callan JMB's standby notification for measles response in Texas represents the potential activation of their emergency logistics infrastructure established during the COVID-19 pandemic. The measles outbreak has reached critical status, having already claimed a life, which typically triggers escalated public health measures. The company's submission of a 24/7 availability roster indicates this is being treated as an urgent situation requiring immediate preparedness.

The mention of their previous distribution of 2 million COVID-19 and MPOX vaccines shows established capability in precisely the kind of cold-chain logistics essential for measles vaccine distribution. Measles outbreaks require rapid containment through targeted vaccination campaigns and possibly quarantine support services, which aligns with Callan's described "pin-point distribution" capabilities. Their experience deploying qualified strike teams for vaccine administration adds a valuable service layer beyond simple logistics that health authorities often need during containment efforts. The state's renewal of their contingency contract after COVID-19 suggests their performance met or exceeded expectations during that larger-scale emergency.

Financial Analyst

This standby activation represents a potential revenue catalyst for Callan JMB that wasn't previously factored into near-term projections. For a microcap company with just $20.5 million market capitalization, even modest contract activations can materially impact quarterly performance. While financial terms aren't disclosed, their five-year contingency contract structure suggests negotiated rates for various emergency services that can be quickly deployed.

The company's previous emergency response work during COVID-19 and MPOX created significant operational activity with the distribution of over 2 million vaccines and therapeutics. This current measles response will likely be smaller in scale but could still generate meaningful revenue for a company of this size. More importantly, this highlights their diversified business model with both standard healthcare logistics and emergency response capabilities providing potential counter-cyclical revenue streams. The contract's contingency nature means minimal carrying costs during inactive periods, with the potential for surge revenue during public health emergencies, creating an attractive business profile with operational leverage. Investors should note this represents the second renewal of their emergency services contract, suggesting Texas authorities see continued value in their specialized capabilities.

Callan JMB received a 5-year contingency contract in 2023 from the State of Texas to receive, store and distribute medical countermeasures as requested by DSHS

SPRING BRANCH, Texas, March 03, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced it has received a request from the State of Texas Department of Health and Human Services to be on standby in readiness to assist with the response to the recent outbreak of measles.

The State of Texas awarded Callan JMB a five-year contingency contract in 2023 to receive, store, and distribute medical countermeasures as requested by the Department of State Health Services (DSHS) for public health emergencies. The current measles outbreak has already taken one life, and the State of Texas is responding to the emergency. Callan JMB is proactively submitting to DSHS a 30-day roster of personnel available 24/7 to handle any receipt and distribution requests immediately.

“Rapid response to public health emergencies is the heartbeat of Callan JMB,” states Wayne Williams, CEO of Callan JMB. “Our primary concern is the welfare of communities, which is why we are always prepared with expert staff, fully equipped facilities, and a top-level quality-controlled inventory management system.”

Callan JMB was awarded its first emergency response contingency contract by the State of Texas in 2018. That contract was activated in 2020 to respond to the COVID-19 and MPOX pandemic. Over the course of the pandemic Callan JMB provided storage and pin-point distribution of over 2 million COVID-19 and MPOX vaccines and therapeutics rapidly and effectively, as well as qualified strike teams to administer vaccines whenever needed. After the COVID and MPOX emergencies were declared over, Callan JMB was awarded its second emergency contingency contract. Using the procedures that were successful in the pandemic, Callan JMB stands ready to mitigate the effects of this new measles outbreak to protect the residents of Texas.

About Callan JMB
Callan JMB is an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. The combined expertise of our CEO, COO and CIO in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our reusable thermal shippers.

Forward-Looking Statement

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Registration Statement Under the Securities Act of 1933 on Form S-1, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254

FAQ

What is Callan JMB's role in the Texas measles outbreak response?

Callan JMB (CJMB) is on standby to receive, store, and distribute medical countermeasures as requested by Texas DSHS, operating under a five-year contingency contract awarded in 2023.

How many vaccines did CJMB distribute during the COVID-19 and MPOX pandemic?

Callan JMB distributed over 2 million COVID-19 and MPOX vaccines and therapeutics during the pandemic response.

When did CJMB receive its first emergency response contract from Texas?

Callan JMB received its first emergency response contingency contract from Texas in 2018.

What services is CJMB preparing to provide for the measles outbreak?

CJMB is preparing 24/7 personnel availability for 30 days to handle receipt and distribution requests, utilizing their facilities and quality-controlled inventory management system.